Overview
Xiuhua Chen practices in Taiyuan, China. Chen is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Leukemia, and Acute Promyelocytic Leukemia.
Their clinical research consists of co-authoring 50 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia
- LeukemiaChen isAdvanced. Learn about Leukemia.
- Myeloproliferative Neoplasms (MPN)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Blood ClotsChen isExperienced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)
- Diabetic KetoacidosisChen isExperienced. Learn about Diabetic Ketoacidosis.
- Disseminated Intravascular Coagulation
- Essential ThrombocythemiaChen isExperienced. Learn about Essential Thrombocythemia.